110 filings
Page 3 of 6
8-K
wx7z4xi664kfnzj0xod
26 Apr 22
Gamida Cell Announces FDA Clearance of IND and Removal of Clinical Hold for NK Cell Therapy Candidate GDA-201
7:30am
8-K
6pnlan6r
15 Mar 22
Gamida Cell Reports Fourth Quarter and Full Year 2021 Financial Results
7:31am
8-K
4k70fe4vwlanhmfq kox
9 Feb 22
On track to complete the BLA submission in the first half of 2022
7:30am
8-K
ys0wh y7z6a07
31 Jan 22
Gamida Cell Announces Appointment of Anat Cohen-Dayag and Naama Halevi-Davidov to its Board of Directors
4:31pm
8-K
3xdnm5v
31 Jan 22
Gamida Cell Provides Key Program Updates and 2022 Financial Guidance
9:00am
8-K
a381061qy h2fcb
19 Jan 22
Gamida Cell Provides Update on Omidubicel BLA Submission
7:00am
8-K
37qx1 rmi3r
3 Jan 22
Regulation FD Disclosure
7:00am
6-K
fn5k7smo0gcfwi
24 Nov 21
Report of Foreign Private Issuer
4:01pm
6-K
m4ds1t 00rt
18 Nov 21
Report of Foreign Private Issuer
4:01pm
6-K
oq8rlxnj94
15 Nov 21
Gamida Cell Reports Third Quarter 2021 Financial Results
7:29am
6-K
79kdst56 loa
12 Nov 21
Gamida Cell Provides Update on Pre-BLA Meeting with FDA for Omidubicel
7:17am
6-K
j3edtfrlpiz
26 Oct 21
Gamida Cell to Present NAM-Enabled, Genetically Modified NK Cell Therapy Pipeline and Update on GDA-201 at Today’s Virtual R&D Day
7:30am
6-K
zp18mdz51o24p7
12 Oct 21
Report of Foreign Private Issuer
4:32pm
6-K
r2ac9z
13 Aug 21
Report of Foreign Private Issuer
4:04pm
6-K
pyhkst
3 Aug 21
Report of Foreign Private Issuer
4:30pm
6-K
l54up6c
25 Jun 21
Current Report
4:15pm
6-K
t0osr
7 Jun 21
Gamida Cell Announces Appointment of Senior Vice President, Global Operations and Manufacturing and Provides Commercial Manufacturing Update
7:11am
6-K
10jfmid
21 May 21
Current report (foreign)
4:15pm
6-K
76bdfigcun0k
11 May 21
Gamida Cell Reports First Quarter 2021 Financial Results and Provides Company Update
8:28am
6-K
tl3n sxcsh1
9 Mar 21
Gamida Cell Reports Full Year 2020 Financial Results and Provides Company Update
4:08pm